← Back to Clinical Trials
Recruiting NCT06971796

NCT06971796 EURO-STIM Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06971796
Status Recruiting
Phase
Sponsor Inspire Medical Systems, Inc.
Condition Obstructive Sleep Apnea
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2025-05-26
Primary Completion 2035-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Inspire UAS System

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2025-05-26 with a primary completion date of 2035-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The registry is to measure longitudinal outcomes and adherence of the Inspire System. The goal of the registry is to capture the life cycle of the patient's use of the Inspire System through routine clinical care visits. There are no required interventions or testing.

Eligibility Criteria

Inclusion Criteria: Any patient implanted with or receiving an Inspire implant, who meets the following criteria, is eligible to participate in the registry: 1. Capable of giving informed consent, as required per institution 2. Willing to return for routine clinic visits as required for Inspire therapy management Exclusion Criteria: Any patient who meets any of the following criteria will not be eligible to participate in the registry: 1. Has a life expectancy of less than one year 2. Any reason the clinician deems patient is unfit for participation in the study

Contact & Investigator

Central Contact

Elyse Ebeling

✉ elyseebeling@inspiresleep.com

📞 (763) 250-9432

Frequently Asked Questions

Who can join the NCT06971796 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06971796 currently recruiting?

Yes, NCT06971796 is actively recruiting participants. Contact the research team at elyseebeling@inspiresleep.com for enrollment information.

Where is the NCT06971796 trial being conducted?

This trial is being conducted at Klagenfurt, Austria, Linz, Austria, Edegem, Belgium, Angers, France and 11 additional locations.

Who is sponsoring the NCT06971796 clinical trial?

NCT06971796 is sponsored by Inspire Medical Systems, Inc.. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology